ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 1,835.00
+5.00 (0.27%)
At close: Jan 23, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 33.36 billion as of January 30, 2026. Its market cap has increased by 74.19% in one year.
Market Cap
33.36B
Enterprise Value
32.87B
Revenue
14.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,835.00
Market Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 33.36B, an increase of 31.61%. That is a compound annual growth rate of 4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 33.36B | 0.44% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MOA Life Plus | 63.52B |
| NGeneBio | 50.45B |
| J2KBIO | 49.65B |
| Aptamer Sciences | 47.42B |
| SCM Lifescience | 36.42B |
| Kainos Medicine | 35.56B |
| Epibiotech | 34.33B |
| Eutilex.Co.,Ltd | 26.89B |